As of the latest SEC filings, Ascendis Pharma A/S (ASND) is held by 276 institutional funds. The largest fund shareholder is T. Rowe Price Capital Appreciation Fund (PACLX), holding an estimated $626,895,635.91 in market value, representing 0.95% of its portfolio.
Funds holding Ascendis Pharma A/S (ASND)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- ASND
- CIK:
- 0001612042
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
PACLX
T. Rowe Price Capital Appreciation Fund
|
MF | T. Rowe Price | 0.95% | $626,895,635.91 | 2,740,767 | Mar 31, 2026 | May 28, 2026 |
|
OTCIX
MFS Mid Cap Growth Fund
|
MF | Independent / Boutique | 2.17% | $298,818,823.00 | 1,279,738 | Feb 28, 2026 | Apr 22, 2026 |
|
AGTHX
Growth Fund of America
|
MF | Capital Group / American Funds | 0.09% | $282,459,112.50 | 1,209,675 | Feb 28, 2026 | Apr 27, 2026 |
|
FKDNX
Franklin Dynatech Fund
|
MF | Franklin Templeton | 1.02% | $251,603,000.00 | 1,100,000 | Mar 31, 2026 | May 27, 2026 |
|
VGHAX
VANGUARD HEALTH CARE FUND
|
MF | Vanguard | 0.65% | $240,835,695.96 | 1,049,942 | Apr 30, 2026 | Jun 26, 2026 |
|
PAMCX
T. Rowe Price Mid-Cap Growth Fund, Inc.
|
MF | T. Rowe Price | 0.80% | $179,187,082.00 | 783,400 | Mar 31, 2026 | May 28, 2026 |
|
FSPHX
Select Health Care Portfolio
|
MF | Fidelity | 2.70% | $167,186,000.00 | 716,000 | Feb 28, 2026 | Apr 24, 2026 |
|
ARTMX
Artisan Mid Cap Fund
|
MF | Independent / Boutique | 5.25% | $155,157,394.39 | 678,343 | Mar 31, 2026 | May 29, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 1.42% | $154,661,050.29 | 676,173 | Mar 31, 2026 | May 28, 2026 |
|
TWCUX
Ultra Fund
|
MF | American Century | 0.57% | $152,308,320.00 | 664,000 | Apr 30, 2026 | Jun 26, 2026 |
|
-
JNL/T. Rowe Price Capital Appreciation Fund
|
ETF | Independent / Boutique | 1.00% | $137,997,154.90 | 603,319 | Mar 31, 2026 | May 28, 2026 |
|
SMCWX
SMALLCAP World Fund Inc
|
MF | Independent / Boutique | 0.16% | $132,472,410.45 | 579,165 | Mar 31, 2026 | May 28, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 2.44% | $130,339,933.50 | 558,201 | Feb 28, 2026 | Apr 24, 2026 |
|
BBGSX
Bridge Builder Small/Mid Cap Growth Fund
|
MF | Independent / Boutique | 1.36% | $125,202,456.13 | 547,381 | Mar 31, 2026 | May 22, 2026 |
|
HISGX
Harbor Small Cap Growth Fund
|
MF | Independent / Boutique | 4.43% | $114,493,421.34 | 499,143 | Apr 30, 2026 | Jun 26, 2026 |
|
ANWPX
New Perspective Fund
|
MF | Independent / Boutique | 0.07% | $105,990,051.05 | 463,385 | Mar 31, 2026 | May 28, 2026 |
|
JAENX
Janus Henderson Enterprise Fund
|
MF | Independent / Boutique | 0.51% | $104,081,756.66 | 455,042 | Mar 31, 2026 | May 29, 2026 |
|
-
Growth Fund
|
ETF | Capital Group / American Funds | 0.21% | $101,761,062.08 | 444,896 | Mar 31, 2026 | May 28, 2026 |
|
FBCHX
Fidelity Blue Chip Growth Fund
|
MF | Fidelity | 0.10% | $94,851,611.94 | 413,513 | Apr 30, 2026 | Jun 26, 2026 |
|
JAGLX
Janus Henderson Global Life Sciences Fund
|
MF | Independent / Boutique | 1.65% | $85,815,607.59 | 375,183 | Mar 31, 2026 | May 29, 2026 |
|
-
CTIVP - Westfield Select Large Cap Growth Fund
|
ETF | Columbia Threadneedle | 5.18% | $81,242,379.97 | 355,189 | Mar 31, 2026 | May 28, 2026 |
|
FACTX
Fidelity Advisor Health Care Fund
|
MF | Fidelity | 2.70% | $77,989,200.00 | 340,000 | Apr 30, 2026 | Jun 26, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.96% | $77,756,306.04 | 339,948 | Mar 31, 2026 | May 28, 2026 |
|
TEGAX
Touchstone Strategic Trust-Touchstone Mid Cap Growth Fund
|
MF | Independent / Boutique | 4.24% | $76,478,162.80 | 334,360 | Mar 31, 2026 | May 29, 2026 |
|
TCAF
T. Rowe Price Capital Appreciation Equity ETF
|
ETF | T. Rowe Price | 1.23% | $76,241,427.25 | 333,325 | Mar 31, 2026 | May 28, 2026 |
Advertisement (320x50)